US12490988B2 - Device and method for altering blood flow characteristics in a vessel - Google Patents
Device and method for altering blood flow characteristics in a vesselInfo
- Publication number
- US12490988B2 US12490988B2 US17/785,356 US202017785356A US12490988B2 US 12490988 B2 US12490988 B2 US 12490988B2 US 202017785356 A US202017785356 A US 202017785356A US 12490988 B2 US12490988 B2 US 12490988B2
- Authority
- US
- United States
- Prior art keywords
- vessel
- cuff
- helical
- cross
- passageway
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00106—Sensing or detecting at the treatment site ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00862—Material properties elastic or resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0462—Apparatus with built-in sensors
- A61B2560/0468—Built-in electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0247—Pressure sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/068—Modifying the blood flow model, e.g. by diffuser or deflector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0091—Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0001—Means for transferring electromagnetic energy to implants
- A61F2250/0002—Means for transferring electromagnetic energy to implants for data transfer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/001—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
Definitions
- the present disclosure relates to a device and method for altering blood flow characteristics in a vessel.
- the vessel is particularly a carotid artery, but may be any vessel (artery or vein).
- the device and method are intended for preventing or at least reducing the risk of cognitive decline.
- the invention may be used in other medical applications.
- the heart supplies oxygenated blood to the body through a network of interconnected, branching arteries starting with the largest artery in the body, the aorta.
- the portion of the aorta closest to the heart is divided into three regions: the ascending aorta (where the aorta initially leaves the heart and extends in a superior direction), the aortic arch, and the descending aorta (where the aorta extends in an inferior direction).
- the brachiocephalic artery extends away from the aortic arch and subsequently divides into the right common carotid artery, which supplies oxygenated blood to the head and neck, and the right subclavian artery, which predominantly supplies blood to the right arm.
- the left common carotid artery extends away from the aortic arch and supplies the head and neck.
- the left subclavian artery extends away from the aortic arch and predominantly supplies blood to the left arm.
- Each of the right common carotid artery and the left common carotid artery subsequently branches into separate internal and external carotid arteries.
- the descending aorta extends downwardly and defines the descending thoracic aorta and subsequently the abdominal aorta before branching into the left and right iliac arteries.
- Various organs of the body are supplied by arteries which junction with and are supplied by the descending aorta.
- the difference between the systolic blood pressure and the diastolic blood pressure is the “pulse pressure,” which generally is determined by the magnitude of the contraction force generated by the heart, the heart rate, the peripheral vascular resistance, and diastolic “run-off” (e.g., the blood flowing down the pressure gradient from the arteries to the veins), amongst other factors.
- Pulse pressure generally is determined by the magnitude of the contraction force generated by the heart, the heart rate, the peripheral vascular resistance, and diastolic “run-off” (e.g., the blood flowing down the pressure gradient from the arteries to the veins), amongst other factors.
- High flow organs, such as the brain are particularly sensitive to excessive pressure and flow pulsatility.
- Other organs such as the kidneys, liver and spleen may also be damaged over time by excessive pressure and flow pulsatility.
- the walls of the arterial vessels expand and contract in response to the pressure wave to absorb some of the pulse wave energy.
- the vasculature ages, however, the arterial walls lose elasticity, which causes an increase in pulse wave speed and wave reflection through the arterial vasculature.
- vascular dementia e.g., an impaired supply of blood to the brain or bleeding within the brain, or a high pulse pressure
- high pulse pressure can be the root cause or an exacerbating factor of vascular dementia and age-related dementia (e.g., Alzheimer's disease).
- the progression of vascular dementia and age-related dementia may also be affected by the loss of elasticity in the arterial walls and the resulting stress on the cerebral vessels.
- Alzheimer's disease for example, is generally associated with the presence of neuritic plaques and tangles in the brain.
- Increased pulse pressure is a hallmark of vascular aging, and has recently been identified to be a potential risk factor for cognitive decline and dementia due to its destructive impact on the fragile microvasculature of the brain.
- Blood pressure is routinely measured and used as an indicator of the presence of various possible underlying conditions.
- blood pressure measurement alone is not a suitable gauge of cognitive decline. This is because a patient's blood pressure may be elevated or varied as a result of various factors which may be unrelated to cognitive decline.
- the likely actual cause of brain damage from high pulse pressure is the “intensity” of the carotid wave as it travels forward into the brain. Accordingly, an increase in the amplitude of pulse-generated waves travelling toward the brain could be an important risk factor for later cognitive decline.
- the present invention provides a device for altering blood flow characteristics in a vessel, the device comprising:
- the passageway is preferably curved about one or more axes which extend generally perpendicular to the direction of blood flow.
- the first abutment formation is preferably defined by a first pad.
- the device further preferably comprises a second pad and a third pad, wherein the three pads a longitudinally separated within the cuff, and spaced around the circumference of the cuff.
- the three pads are preferably evenly spaced circumferentially at about 120 degrees relative to each adjacent pad.
- the device further preferably comprises a second pad diametrically opposed relative to the first pad, and in axial alignment with the first pad, defining a first pair of pads.
- the device further preferably comprises a second pair of pads which are also diametrically opposed and axially aligned.
- the first pair of pads is preferably longitudinally spaced relative to the second pair of pads to define an expansion chamber within the cuff.
- the device further preferably comprises a third pair of pads which are also diametrically opposed and axially aligned.
- the first pair of pads is preferably located adjacent to a proximal end of the device and the second pair of pads is preferably located adjacent to a distal end of the device, the first and second pairs of pads being in circumferential alignment.
- the third pair of pads is preferably located between the first pair of pads and the second pair of pads, further wherein the third pair of pads is circumferentially offset by about 90 degrees.
- the pads are preferably gel filled.
- the cuff is preferably defined by a generally tubular body.
- the cuff preferably includes a longitudinally extending seam which permits the cuff to be placed around the vessel.
- the seam is preferably defined by first and second longitudinally extending arms which are selectively securable to each other.
- the cuff is preferably defined by an elastically deformable helical body which is coated in a compliant layer.
- the elastically deformable helical body is preferably fabricated from NitinolTM and the compliant layer is preferably fabricated from silicone.
- a radially internal surface of the compliant layer is preferably curved, such that a cross sectional area of the compliant layer is generally “D” shaped when sectioned through a plane which is parallel with and passes through a longitudinal axis of the helical body.
- D cross sectional area of the compliant layer
- a radially internal surface of the compliant layer preferably includes at least one inwardly extending projection.
- the present invention provides a method of altering blood flow characteristics within a vessel, the method including the steps of:
- the present invention provides a device for altering blood flow characteristics in a vessel, the device comprising:
- a cable is preferably located adjacent to the central spine, the cable extends between proximal and distal ends of the device, the cable length being selectively adjustable to change the shape of the helix, such that shortening the cable reduces a pitch of the helix and increases a diameter of the helix.
- a cross section of the central spine preferably varies along the length of the device between proximal and distal ends.
- a cross-section of the helical cuff preferably varies along the length of the device between proximal and distal ends.
- the device further preferably comprises one or more sensors located on the helical cuff for obtaining data relating to blood flow characteristics within the vessel and/or vessel characteristics.
- the sensors preferably include one or more of electrodes, pressure sensors and ultrasonic emitters.
- the sensor(s) is preferably located on a radially internal portion of the helical cuff, positionable in direct abutment with the vessel.
- the sensors are preferably configured to wirelessly communicate with a computer or other such device to transmit information concerning measured blood flow characteristics and/or vessel characteristics.
- a cross sectional shape of the passageway preferably varies along the length of the device between proximal and distal ends.
- FIG. 1 is a schematic diagram of a human heart
- FIG. 2 is a schematic view of a device for modifying blood flow characteristics according to a first embodiment of the invention
- FIG. 3 is a further schematic view of the device of FIG. 2 ;
- FIG. 4 depicts a device for modifying blood flow characteristics according to a second embodiment of the invention
- FIG. 5 depicts a device for modifying blood flow characteristics according to a third embodiment of the invention.
- FIG. 6 depicts a device for modifying blood flow characteristics according to a fourth embodiment of the invention.
- FIG. 7 is side view of a device for modifying blood flow characteristics according to a fifth embodiment when deployed.
- FIG. 8 is a perspective view of the device of FIG. 7 ;
- FIG. 9 is a further side view of the device for modifying blood flow characteristics according to FIG. 7 ;
- FIG. 10 is a cross-sectional side view of a portion of the device of FIG. 7 ;
- FIG. 11 is a cross-sectional side view of a portion of the device of FIG. 7 when deployed;
- FIG. 12 is a front view of a device according to a sixth embodiment.
- FIG. 13 is top view of the device of FIG. 12 ;
- FIG. 14 is an end view of a device of FIGS. 12 and 13 ;
- FIG. 15 is a partial detail of the end view of FIG. 14 ;
- FIG. 16 is a perspective view of the device of FIGS. 12 to 15 .
- the cuff 10 deforms the arterial wall and as a result alters the blood flow characteristics within a passage 9 of the vessel 20 , by changing the geometry of the vessel 20 such that along the length of the cuff 10 , the vessel 20 wall profile is altered.
- the change in vessel 20 structure may result in a change of cross-sectional shape, and/or cross-sectional area and/or vessel curvature or bending about an axis which extends generally perpendicular to the direction of flow (i.e. the vessel is locally made non-linear).
- the device 15 , 50 , 55 , 60 , 100 , 200 is preferably placed around the outside of the common carotid artery. Its intended function is to modify the dynamics of transmission of arterial blood pressure to the cerebral microvasculature and to absorb excess energy from the arterial pulse.
- Each embodiment of the device 15 , 50 , 55 , 60 , 100 , 200 includes a member which is placed around the vessel during a surgical procedure.
- the device 15 , 50 , 55 , 60 , 100 , 200 the device 15 , 50 , 55 , 60 , 100 , 200 :
- the device 15 includes a cuff 10 which forces a portion of the vessel 20 to adopt a bent or curved profile, having curvature about one or more axes which extend generally perpendicular to the direction of blood flow (i.e. the vessel 20 becomes locally non-linear).
- the cuff 10 includes an outer scaffold 30 fabricated from a suitable biocompatible material such as stainless steel or Nitinol.
- the scaffold 30 may be formed as two halves and located around the vessel and attached to each other. Alternatively, the scaffold may be fabricated as a single component which is sufficiently compliant to allow it to be wrapped around the vessel, prior to subsequent attachment of the two opposing sides to define a generally tubular cuff 10 .
- Abutment formations in the form of pads or buffers 40 are located on the radial inner wall of the cuff 10 .
- the pads 40 are preferably gel pads 40 and may be defined by a single gel pad 40 , or a plurality of independent gel pads 40 .
- the gel pads 40 cause the deformation of the vessel 20 , forcing the vessel 20 to adopt a curving profile, within the wall of the scaffold 30 which is generally locally cylindrical.
- the curvature of the deformed vessel 20 as depicted schematically in FIG. 1 has a central concave region and adjacent convex regions, such that the blood flow path is significantly diverged away from linear.
- the pads 40 are not limited to gel pads, and may be fabricated from other material such as polymers of varying hardness or gas filled cushions.
- the gel pads 40 serve two purposes. Firstly, the gel pads 40 define the desired deformation in the wall of the blood vessel 20 . Secondly, the gel pads 40 dampen the energy carried by the blood flow when the blood flow comes into contact with the wall of the vessel 20 , as the outer wall of the vessel 20 is in direct abutment with the gel pads 40 .
- the blood flow Due to the deformation of the vessel 20 , the blood flow is forced to adopt a non-linear path within the cuff 10 . Accordingly, the pressure wave, which travels axially within a vessel 20 , contacts the wall of the vessel 20 , which in turn is supported against the gel pad 40 . The gel pad 40 absorbs some of the energy carried by the blood flow.
- the deformation of the vessel 20 results in the reflected portion of the pressure wave being non-axial relative to the vessel 20 . This typically results in the reflected wave coming into contact with the wall of the vessel 20 at several other locations, which may also reduce the energy intensity carried by the pressure wave downstream of the cuff 10 .
- the gel pad 40 and the cuff 10 are arranged to introduce curvature into the vessel 20 , while maintaining a generally circular cross-sectional area in the vessel 20 , such that the vessel 20 generally maintains native diameter.
- the cuff 10 may also alter the cross-sectional area or shape of the vessel 20 .
- the vessel along its length can be partially flattened into an oval or elliptical cross-section, which has a cross-sectional area which is less than the native cross-sectional area of the vessel 20 .
- the modified cross-section of the vessel 20 may be any shape, but typically the overall cross-section is flattened and widened.
- Such partial flattening of the vessel 20 may desirably increase the ability of the vessel to become curved, due to the ribbon-like cross-sectional profile (once flattened) being more readily deformed.
- the diameter (and length) of the passageway 25 passing through the tubular scaffold 30 relative to the native outer diameter of the vessel 20 defines the amount of curvature of the vessel which may be introduced by a given cuff 10 .
- FIG. 4 A second embodiment of the device 50 is depicted in FIG. 4 .
- there are three gel pads 40 arranged around the circumference of the cuff 10 .
- Each of the gel pads 40 is approximately evenly spaced longitudinally. Circumferentially the gel pads 40 are offset at approximately 120 degrees relative to each adjacent gel pad 40 .
- the radial spacing of the gel pads 40 forces the blood flow to follow a more circuitous (non-linear) path.
- this arrangement promotes several points of contact where the axial pressure wave carried by the blood flow is forced to contact the vessel 20 wall at a location which is supported by one of the gel pads 40 .
- each gel pad 40 only partially restricts or changes the shape of the local cross-sectional area of the vessel 20 . Accordingly, the volumetric blood flow through the device 50 is not significantly affected, as the local cross-sectional area of the vessel 20 is not changed significantly relative to the natural cross-sectional area of the vessel 20 at any location. As such, the device 50 is able to deflect and/or absorb some of the energy carried by the pressure wave without significantly obstructing the volumetric blood flow rate.
- the scaffold is defined by a tube which is placed around the vessel and has a longitudinal split defining two arms 35 .
- the arms 35 may be secured to each other with welding, stitching, gluing, stapling, corresponding male and female engagement formations or some other means which permits the arms 35 to be attached to each other quickly during surgery. It will be appreciated that in an embodiment in which the scaffold is made from a metallic material such as nitinol, the engagement may not be necessary.
- a third embodiment of the device 55 is depicted in FIG. 5 .
- the third embodiment is functionally similar to the second embodiment described above. However, there are three pairs of gel pads 40 .
- the first pair of gel pads 42 are arranged diametrically opposite each other at a first (proximal) end 52 of the device 55 .
- a second pair of gel pads 46 is arranged diametrically opposite each other, generally at a second (distal) end 56 of the device 55 .
- a third pair of gel pads 44 are arrange adjacent to the first pair, at a longitudinally central region 54 of the device 55 .
- the third pair of gel pads 44 is circumferentially offset relative to the first and second pairs of gel pads 42 , 46 by about 90 degrees.
- Each pair of gel pads 42 , 44 , 46 locally flattens the vessel 20 , such that the vessel 20 locally adopts an oval or elliptical profile, or at least a non-circular profile. In this way, at the junction between each pair of gel pads 42 , 44 , 46 , the pressure waves contact with a step like change in vessel 20 geometry.
- a fourth embodiment of the device 60 is depicted in FIG. 6 .
- the fourth embodiment is similar to the third embodiment described above but the central pair of gel pads are omitted.
- there is a first pair of gel pads 62 located at a first end 64 of the device 60 and a second pair of gel pads 66 located at an opposing second end 68 of the device 60 .
- the space between the sets of gel pads 62 , 66 defines an expansion chamber 70 , located in a longitudinally central region of the device 60 .
- the expansion chamber 70 permits the vessel 20 to locally expand or balloon, which may result in remodelling of the vessel geometry and which may reduce pressure within the vessel 20 .
- the expansion of the portion of the vessel 20 located within the region of the expansion chamber 70 may occur permanently within the device 60 , or as a result of changes in blood pressure within the vessel.
- the gel pads 62 , 66 may be circumferentially angularly offset relative to each other by about 90 degrees, and with the expansion chamber 70 located in between.
- pads described in each embodiment have been described as separately formed components, it will be appreciated that the pads may be integrally formed with the cuff 10 .
- FIGS. 7 to 11 A fifth embodiment of the device 100 is depicted in FIGS. 7 to 11 .
- the device 100 has a generally helical body or cuff 110 , and in a similar manner to the earlier described embodiments, the device 100 is intended to be externally placed around the outside of the common carotid artery or the internal carotid artery.
- the device 100 has a helical profile, so that it can be placed around the vessel 20 with minimal disturbance during a surgical procedure, with the elasticity of the device 100 permitting the vessel 20 to be seated radially within the central passageway 25 extending longitudinally through the helix of the device 100 .
- the device 100 includes a central spine 120 fabricated from an elastically deformable material such as medical grade NitinolTM or another suitable metal, metal alloy or polymer.
- the spine 120 is sheathed in a covering of silicone 130 or another suitable polymer.
- the silicone 130 is compliant, and reduces the risk of any damage to the external wall of the vessel 20 . Whilst the device is depicted with the covering of silicone 130 , it could alternatively be fabricated without the covering 130 such that the spine 120 defines the external surface for abutment with the vessel 20 .
- the device 100 is a single piece device with no articulated parts, constructed in the form of an open spiral helix with a total length of preferably about 45 mm, but may be provided in different lengths, in the range of 20-55 mm for the common carotid artery but may be longer or shorter in other vessels 20 .
- the device 100 is designed to fit around the outside of the common carotid artery or internal carotid artery, and deflects the artery (smoothly and continuously) along the length of the artery segment.
- an 8 mm diameter common carotid artery would be deflected approximately 6 degrees from its long axis a number of times as it passes through the device 100 .
- the artery 20 resumes its native path on exiting the device 100 .
- the internal helix diameter of the device 100 defining the central passageway 25 is chosen to be less than the local artery external diameter in order to suitably deflect the artery.
- the device 100 deforms the artery only at points of contact, that is, along the helix, it does not substantially alter the cross-sectional area nor the shape of the artery, because at no point does the device completely encircle the artery. If the pitch is small enough, the device 100 can reduce the diameter of the artery. In that case it can deflect as well as reduce the cross-sectional area of the artery.
- the pitch of the device 100 may be constant or variable. If the helix pitch is sufficiently fine, the device 100 may behave like a continuous tube, with minimal or no clearance between adjacent crests of the helix.
- the central helical spine 120 is fabricated from a wound plate section of NitinolTM, such that the spine 120 is wound about the longitudinal helix axis
- the spine 120 is resiliently deformable, and can be unwound to wrap around the vessel 20 before springing back to the native diameter of the device 100 .
- the helical spine 120 is preferably preformed in a self supporting helix and fabricated for example in a heat-set process.
- the cross-sectional shape of the silicone covering 130 is generally contoured, such that the profile is an obround, ellipse, oval or another such formation. This creates gradual deformation of the vessel 20 , and reduces the risk of damage to the vessel 20 . This also assists to create a gradual transition within the vessel 20 from the region of native diameter to the region which is deformed by the device 100 .
- the radially outer surface of the silicone 130 may be defined by a portion of a cylinder or tube, such that the radially outer surface is locally parallel with a longitudinal axis of the device 100 .
- the radially internal surface of the silicone 130 is curved, such that the cross-sectional area of the silicone 130 is generally “D” shaped when sectioned through a plane which is parallel with and passes through a longitudinal axis of the helix.
- the device 100 is intended to locally alter the vessel by changing its shape and/or diameter and/or flow direction.
- the device 100 may reduce the native cross-sectional area of the vessel by between about 5% and 30% and preferably by between about 10% and 20% and most preferably about 15%.
- the reduction in cross-sectional area may be higher, and up to 50%.
- the device 100 is fabricated in different helix diameters, and the device 100 having the most suitable dimensions is chosen before the surgical procedure to achieve an optimal fit to the patient's vessel geometry, and the intended restriction in cross-sectional area. It is envisaged that the device 100 may be supplied in about 12 different sizes, and the preferred size may be determined by imaging the vessel 20 prior to surgery.
- Another means of reducing the passageway 25 in the device 100 is by changing the silicone covering 130 to a thicker or thinner version on the inside of the device. Also, by placing a cable at one end and pulling from the other end, the device may be shortened and inner diameter increased.
- the nitinol spine may be a hollow tube. The cable may be shortened or lengthened by rotating a screw on one end of the device as described in the sixth embodiment below.
- the length of the device 100 is equal to a multiple of approximately 1.5 ⁇ the pitch. It will be appreciated that the length of the device 100 may be some other multiple of the pitch, for example between about 1 and 2 ⁇ pitch. In more extreme cases the coil can be up to 30 ⁇ the pitch or more. Alternatively, the device 100 may be provided in a fixed length, not related to pitch.
- inwardly extending projections 140 may be formed on the internal wall of the silicone covering 130 .
- the projections 140 assist to further locally deform the vessel 20 .
- the projections 140 may be intermittently spaced along the length of the helix and are each directed radially inwardly.
- the ratio of the cross-sectional area of the NitinolTM spine 120 relative to the silicone 130 may vary beyond the embodiment depicted in the drawings.
- the stiffness of the device 100 may be increased.
- the nitinol may vary in cross-section along the length, so the ends are stiff and middle is soft for instance.
- the helix device 100 of the fifth embodiment operates in a similar manner to the earlier described embodiment of FIG. 4 .
- the pads 40 are arranged in a formation which is functionally similar to the helix of the fifth embodiment.
- the silicone of the fifth embodiment which is located on the internal surface of the helix provides cushioning against the external wall of the vessel, in a similar manner to the pads 40 of the first to fourth embodiments.
- FIGS. 12 to 16 A sixth embodiment of the device 200 is depicted in FIGS. 12 to 16 , being a variation on the fifth embodiment 100.
- the device 200 has a generally helical body or cuff 210 , and in a similar manner to the earlier described embodiments, the device 200 is intended to be externally placed around the outside of the common carotid artery or the internal carotid artery (or another suitable vessel).
- the radially inner wall of the cuff 210 may be smooth or textured.
- the device 200 has a helical profile, so that it can be placed around the vessel 20 with minimal disturbance during a surgical procedure, with the elasticity of the device 200 permitting the vessel 20 to be seated radially within the central passageway 25 extending longitudinally through the helix.
- the device 200 includes a central spine 220 fabricated from an elastically deformable material such as medical grade NitinolTM, stainless steel, or another suitable metal, metal alloy or polymer.
- the spine 220 is sheathed in a covering of silicone 230 , or another biocompatible polymer.
- the silicone covering 230 is compliant, may contain and/or release a drug and reduces the risk of any damage to the external wall of the vessel 20 .
- a tensioning wire or cable 240 extends through the helix, adjacent to the central spine 220 .
- the tensioning wire 240 is secured to the central spine 220 with a number of spaced anchoring points 250 .
- the anchoring points 250 may be provided in various different forms, such as lugs 250 with eyelets to receive the wire 240 .
- the tensioning wire 240 may be passed through the centre of a hollow spine 220 .
- the cable 240 has an adjustment mechanism 260 located at one end of the device 200 .
- the adjustment mechanism 260 may be in the form of an interacting thread and nut, a worm drive, a hose clamp type slotted screw, or some other mechanism which is configured to selectively mechanically shorten the length of the cable 240 .
- shortening the cable 240 because the cable is attached to the central spine 220 at each end, and intermittently with the anchoring points 250 , shortening of the cable 240 results in the helix being reduced in length and increased in diameter. This has the effect of radially expanding the device 200 around the vessel.
- the radial expansion or compression of the helix may be performed manually during installation, or alternatively, it may be performed remotely or mechanically in a post-operative procedure, as will be discussed below.
- the cable 240 can be intermittently or occasionally adjusted, for example remotely or mechanically in a keyhole surgical procedure. Such adjustment can be performed to accommodate changes in the vessel, changes in the patient's blood flow characteristics or for any other purpose.
- the device 200 includes a radio component 280 and a copper coil winding 290 , or other such antennae.
- the radio component can receive signals, such as directing the helix to expand or contract in diameter.
- the device 200 also includes tabs 300 that contain sensors that oppose other relevant components located on the helix, such that measurements can be taken on diametrically opposing sides of the helix.
- One such component may be a mirror or reflector 320 for ultrasound purposes, or an LED receiver 330 .
- Various sensors or communication devices may be provided on the spine 220 or sheathed covering of silicone 230 , such as platinum electrodes, 340 , a pressure sensor 360 , an ultrasonic emitter 380 .
- the electrodes 340 and the pressure sensor 360 extend radially inwardly through the surface of the silicone covering 230 , such that the electrodes 340 and the pressure sensor 360 can be placed into direct contact with the wall of the blood vessel 20 .
- the central spine 220 may be fabricated from a sandwiched nitinol helix 400 .
- the sensors and adjustment mechanism of the device 200 may be controlled by a printed circuit board (PCB), such as the doubled-up flex PCB 410 depicted in FIG. 15 .
- PCB printed circuit board
- the cuff 10 is typically around 40-50 mm in length, although it may be longer or shorter.
- the vessel 20 when treated with the device of each of the 1 st to 4 th embodiments described above may be reduced in diameter by about 3% to 30%, and preferably about 5% to 15% and most preferably about 10% by each pad.
- changing the internal diameter of the device 15 , 50 , 55 , 60 may be achieved by changing the dimensions of the silicone covering 130 .
- changing the internal diameter of the helix may be achieved by changing the dimensions (in particular the thickness) of the silicone covering 120 or the dimensions of the spine 130 .
- changing the internal diameter can be achieved by a mechanism such as cable foreshortening, for example as described with respect to the sixth embodiment.
- cross-section of the silicone covering 130 may be constant between the proximal and distal ends.
- the cross-section of the silicon covering 130 may vary between the proximal and distal ends.
- there may be variation of cross-section of the central spine 220 which is preferably fabricated from Nitinol.
- the cuff 10 when placed around a vessel 20 such as the carotid artery, the cuff 10 does not significantly affect the blood flow rate, as the auto-regulation of the blood flow assists in maintaining the natural volumetric blood flow rate.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pathology (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Prostheses (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
-
- a cuff configured to be surgically positioned around a portion of the vessel;
- a first abutment formation located on an internal wall of the cuff,
- wherein the abutment formation:
- locally reduces a cross-sectional area of a passageway extending through the cuff and/or
- defines a passageway within the cuff which is non-linear.
-
- surgically positioning a cuff around a portion of the vessel, and
- locally altering blood flow characteristics in the vessel with one or more abutment formation located within the cuff, the abutment formation:
- reducing a cross-sectional area of a passageway extending through the vessel and/or
- deforming the vessel to define a region which is curved about one or more axes which extend generally perpendicular to the direction of blood flow.
-
- a helical cuff configured to be surgically positioned around a portion of the vessel, a first abutment formation defined by an internal wall of the helical cuff, and
- a central spine located within the helical cuff,
- wherein the abutment formation:
- locally reduces a cross-sectional area of a passageway extending through the cuff and/or
- changes a cross-sectional shape of the passageway extending through the cuff and/or
- defines a passageway within the cuff which is non-linear.
-
- locally reduces or changes the shape of a cross-sectional area of a vessel 20; and/or deforms the vessel 20 extending through the passageway 25 which is non-linear and typically curved or bent about one or more axes which extend generally perpendicular to the direction of blood flow (i.e. the vessel is made locally non-linear).
Claims (13)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019904753 | 2019-12-16 | ||
| AU2019904753A AU2019904753A0 (en) | 2019-12-16 | A device and method for altering blood flow characteristics in a vessel | |
| PCT/AU2020/051377 WO2021119737A1 (en) | 2019-12-16 | 2020-12-16 | A device and method for altering blood flow characteristics in a vessel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20240108348A1 US20240108348A1 (en) | 2024-04-04 |
| US12490988B2 true US12490988B2 (en) | 2025-12-09 |
Family
ID=76476526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/785,356 Active 2042-04-02 US12490988B2 (en) | 2019-12-16 | 2020-12-16 | Device and method for altering blood flow characteristics in a vessel |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12490988B2 (en) |
| EP (1) | EP4076272A4 (en) |
| JP (1) | JP7744343B2 (en) |
| CN (1) | CN115243642A (en) |
| AU (1) | AU2020408369A1 (en) |
| WO (1) | WO2021119737A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020408369A1 (en) | 2019-12-16 | 2022-06-23 | The Brain Protection Company PTY LTD | A device and method for altering blood flow characteristics in a vessel |
| CN119896513A (en) * | 2025-04-02 | 2025-04-29 | 清华大学 | Ultrasound thrombolysis device |
Citations (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
| US3726279A (en) | 1970-10-08 | 1973-04-10 | Carolina Medical Electronics I | Hemostatic vascular cuff |
| US4881939A (en) | 1985-02-19 | 1989-11-21 | The Johns Hopkins University | Implantable helical cuff |
| US5002531A (en) | 1986-06-26 | 1991-03-26 | Tassilo Bonzel | Dilation catheter with an inflatable balloon |
| US5100429A (en) | 1989-04-28 | 1992-03-31 | C. R. Bard, Inc. | Endovascular stent and delivery system |
| US5222980A (en) | 1991-09-27 | 1993-06-29 | Medtronic, Inc. | Implantable heart-assist device |
| WO1996032077A1 (en) | 1995-04-11 | 1996-10-17 | The University Of Queensland | Artificial graft prosthesis |
| US5618301A (en) | 1993-10-07 | 1997-04-08 | Angiomed Ag | Reducing stent, device with reducing stent and use of a reducing stent |
| US5634895A (en) | 1994-06-23 | 1997-06-03 | Cormedics Corp. | Apparatus and method for transpericardial delivery of fluid |
| US5665117A (en) | 1995-11-27 | 1997-09-09 | Rhodes; Valentine J. | Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use |
| US5702419A (en) | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
| US5755777A (en) | 1991-10-25 | 1998-05-26 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
| US5800524A (en) | 1994-12-16 | 1998-09-01 | Bard Galway Limited | Prosthesis with spiral stitching element |
| US5800526A (en) | 1995-03-17 | 1998-09-01 | Endotex Interventional Systems, Inc. | Multi-anchor stent |
| US5919224A (en) | 1997-02-12 | 1999-07-06 | Schneider (Usa) Inc | Medical device having a constricted region for occluding fluid flow in a body lumen |
| US6010529A (en) | 1996-12-03 | 2000-01-04 | Atrium Medical Corporation | Expandable shielded vessel support |
| US6030336A (en) | 1996-02-21 | 2000-02-29 | Synthelabo Biomedical (Societe Anonyme) | Pressure generator for a counterpressure cardiac assistance device |
| US6042605A (en) | 1995-12-14 | 2000-03-28 | Gore Enterprose Holdings, Inc. | Kink resistant stent-graft |
| US6120534A (en) | 1997-10-29 | 2000-09-19 | Ruiz; Carlos E. | Endoluminal prosthesis having adjustable constriction |
| US6129756A (en) | 1998-03-16 | 2000-10-10 | Teramed, Inc. | Biluminal endovascular graft system |
| US6241691B1 (en) | 1997-12-05 | 2001-06-05 | Micrus Corporation | Coated superelastic stent |
| WO2001056501A1 (en) | 2000-02-07 | 2001-08-09 | S & G Biotech Inc. | Blood vessel graft and graft introducer |
| US20010027338A1 (en) | 2000-03-03 | 2001-10-04 | Cook Incorporated | Endovascular device having a stent |
| US6350282B1 (en) | 1994-04-22 | 2002-02-26 | Medtronic, Inc. | Stented bioprosthetic heart valve |
| US6395019B2 (en) | 1998-02-09 | 2002-05-28 | Trivascular, Inc. | Endovascular graft |
| US20020188341A1 (en) | 2001-05-10 | 2002-12-12 | Elliott Christopher J. | Stent with detachable tethers and method of using same |
| US20030065303A1 (en) | 2001-09-28 | 2003-04-03 | Wellman Parris S. | Methods and devices for treating diseased blood vessels |
| WO2003028522A2 (en) | 2001-03-27 | 2003-04-10 | Neovasc Medical Ltd. | Flow reducing implant |
| US20030125797A1 (en) | 2001-12-20 | 2003-07-03 | Trivascular, Inc. | Advanced endovascular graft |
| US20040010303A1 (en) | 2001-09-26 | 2004-01-15 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
| WO2004026112A2 (en) | 2002-09-17 | 2004-04-01 | Tricardia, Llc | Vascular compliance device and method of use |
| WO2004056274A1 (en) | 2002-12-19 | 2004-07-08 | Unisearch Limited | A method of treating a stiffened blood vessel |
| US20040147803A1 (en) | 2002-10-07 | 2004-07-29 | Hegde Anant V. | Vascular assist device and methods |
| WO2004106971A1 (en) | 2003-05-30 | 2004-12-09 | Mitsubishi Denki Kabushiki Kaisha | Coherent laser radar |
| US20040260384A1 (en) | 2003-06-17 | 2004-12-23 | Medtronic Ave | Superelastic coiled stent |
| US20050021023A1 (en) | 2003-07-23 | 2005-01-27 | Scimed Life Systems, Inc. | System and method for electrically determining position and detachment of an implantable device |
| US20050049677A1 (en) | 2001-11-09 | 2005-03-03 | Farnan Robert C. | Baloon catherter with non-deployable stent |
| WO2005041783A1 (en) | 2003-10-30 | 2005-05-12 | Sunshine Heart Company Pty Ltd | A wrap |
| WO2005084730A1 (en) | 2004-03-02 | 2005-09-15 | Peter William Walsh | A vessel or sac wall treatment and a cardiac assist device |
| DE102004018255A1 (en) | 2004-04-15 | 2005-11-10 | Universitätsklinikum Schleswig-Holstein | Vessel prosthesis for maintaining the air chamber function of large blood vessel systems, e.g. the aorta, comprises a tube having an inner wall provided with an elastic flexible lining |
| US6974473B2 (en) | 2000-06-30 | 2005-12-13 | Vascular Architects, Inc. | Function-enhanced thrombolytic AV fistula and method |
| US6984201B2 (en) | 2000-09-23 | 2006-01-10 | Harefield Cardiac Limited | Blood circulation assistance device |
| US20060025852A1 (en) | 2004-08-02 | 2006-02-02 | Armstrong Joseph R | Bioabsorbable self-expanding endolumenal devices |
| US20060100530A1 (en) | 2000-11-28 | 2006-05-11 | Allez Physionix Limited | Systems and methods for non-invasive detection and monitoring of cardiac and blood parameters |
| US20060106449A1 (en) | 2002-08-08 | 2006-05-18 | Neovasc Medical Ltd. | Flow reducing implant |
| WO2006062976A2 (en) | 2004-12-07 | 2006-06-15 | Cook Incorporated | Methods for modifying vascular vessel walls |
| US7125464B2 (en) | 2001-12-20 | 2006-10-24 | Boston Scientific Santa Rosa Corp. | Method for manufacturing an endovascular graft section |
| US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
| WO2007038476A2 (en) | 2005-09-26 | 2007-04-05 | Atteneux Technologies, Inc. | Pressure attenuation device |
| WO2008061185A1 (en) | 2006-11-15 | 2008-05-22 | Georgia Tech Research Corporation | Flow manipulation in biological flows using vortex generators |
| US20090177279A1 (en) | 2005-07-21 | 2009-07-09 | The Cleveland Clinic Foundation | Medical oscillating compliance devices and uses thereof |
| US7575594B2 (en) | 2004-12-30 | 2009-08-18 | Sieracki Jeffrey M | Shock dampening biocompatible valve |
| US20100030253A1 (en) | 2005-11-18 | 2010-02-04 | C.R. Brard, Inc. | Vena cava filter with filament |
| US20100056978A1 (en) | 2008-08-27 | 2010-03-04 | Lindsay Machan | Externally adjustable blood flow valve |
| US20100256735A1 (en) | 2009-04-03 | 2010-10-07 | Board Of Regents, The University Of Texas System | Intraluminal stent with seam |
| US7819941B2 (en) | 2005-06-08 | 2010-10-26 | Sms Siemag Aktiengesellschaft | Method for reducing and/or refining a metal-containing slag |
| US20110106240A1 (en) | 2000-03-03 | 2011-05-05 | Chuter Timothy A M | Large vessel stents and occluders |
| US20110144669A1 (en) | 2007-09-11 | 2011-06-16 | Nfocus Neuromedical Inc. | Aneurysm cover device for embolic delivery and retention |
| US20110166240A1 (en) | 2005-12-27 | 2011-07-07 | Monosol Rx, Llc | Ph modulated films for delivery of actives |
| US20110196967A1 (en) | 2008-10-22 | 2011-08-11 | Fujitsu Limited | Communication control apparatus, communication control system, and communication control method |
| US20110213408A1 (en) | 2005-07-25 | 2011-09-01 | Vascular Dynamics Inc. | Devices and methods for control of blood pressure |
| US20110264116A1 (en) * | 2009-12-31 | 2011-10-27 | Gordon Kocur | Compressive Denervation Apparatus for Innervated Renal Vasculature |
| WO2012018590A1 (en) | 2010-07-26 | 2012-02-09 | Judah Weinberger | Blood flow controllers and methods |
| US20120089218A1 (en) | 2010-10-11 | 2012-04-12 | Dardi Peter S | Hydrogel jacketed stents |
| WO2012071395A1 (en) | 2010-11-22 | 2012-05-31 | Aria Cv, Inc. | System and method for reducing pulsatile pressure |
| US20130013051A1 (en) | 2009-12-08 | 2013-01-10 | Endospan Ltd. | Endovascular stent-graft system with fenestrated and crossing stent-grafts |
| WO2013013081A1 (en) | 2011-07-20 | 2013-01-24 | Stryker Corporaton | Manifold for filling plural cannulae |
| US20130066416A1 (en) | 1994-02-09 | 2013-03-14 | Scimed Life Systems, Inc. | Bifurcated endoluminal prosthesis |
| US20130079871A1 (en) | 2010-06-08 | 2013-03-28 | Regents Of The University Of Minnesota | Vascular elastance |
| EP2586402A1 (en) | 2011-10-27 | 2013-05-01 | Cook Medical Technologies LLC | Stent with inwardly-directed protrusion |
| WO2013084235A2 (en) | 2011-12-04 | 2013-06-13 | Endospan Ltd. | Branched stent-graft system |
| US20130172981A1 (en) | 2005-07-25 | 2013-07-04 | Vascular Dynamics, Inc. | Devices and methods for control of blood pressure |
| US20130218191A1 (en) | 2010-04-26 | 2013-08-22 | Paul Heltai | Method for deploying a sleeve and tubing device for restricting and constricting aneurysms and a sleeve and tubing device and system |
| US20130226280A1 (en) | 2011-08-29 | 2013-08-29 | Aortic Wrap Pty Ltd | Method and Device For Treating a Stiffened Blood Vessel |
| US20130296917A1 (en) | 2012-05-04 | 2013-11-07 | Interventco Llc | Device and Method for Filling of Aneurysm or Body Cavity |
| US20140058436A1 (en) | 2011-02-18 | 2014-02-27 | Sequent Medical, Inc. | Blood flow disruption devices and methods for the treatment of vascular defects |
| US8708906B1 (en) | 2011-09-07 | 2014-04-29 | Allen J. Orehek | Method for the prevention of dementia and Alzheimer's disease |
| US8876850B1 (en) | 2014-06-19 | 2014-11-04 | Aria Cv, Inc. | Systems and methods for treating pulmonary hypertension |
| WO2014186755A2 (en) | 2013-05-16 | 2014-11-20 | Sarvazyan Narine | Myocyte-derived flow assist device: extravasal sheaths of rhythmically contracting myocytes aiding flow of biological fluids |
| US20150025625A1 (en) | 2013-07-18 | 2015-01-22 | The Trustees Of The University Of Pennsylvania | Cardiac repair prosthesis sets and methods |
| WO2016128983A1 (en) | 2015-02-12 | 2016-08-18 | Hemodynamx-Technologies Ltd. | Aortic implant |
| US9492293B2 (en) | 2001-03-13 | 2016-11-15 | Medinol Ltd. | Method and apparatus for stenting |
| US20170042551A1 (en) | 2015-08-13 | 2017-02-16 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US9592068B2 (en) | 2013-03-15 | 2017-03-14 | Insera Therapeutics, Inc. | Free end vascular treatment systems |
| US20170087045A1 (en) | 2015-09-28 | 2017-03-30 | Michael Zhadkevich | Device and method for simultaneous detection, monitoring and prevention of cerebral emboli |
| US20170172771A1 (en) | 2014-07-20 | 2017-06-22 | Elchanan Bruckheimer | Pulmonary artery implant apparatus and methods of use thereof |
| US20170173262A1 (en) | 2017-03-01 | 2017-06-22 | François Paul VELTZ | Medical systems, devices and methods |
| US20170354421A1 (en) * | 2016-06-10 | 2017-12-14 | Microvention, Inc. | Vessel Occluder |
| WO2018027298A1 (en) | 2016-08-12 | 2018-02-15 | Gand François | Portable alzheimer detector |
| WO2018064769A1 (en) | 2016-10-04 | 2018-04-12 | Toubib Media Inc. | Method for generating cognitive decline detection tool, method for measuring cognitive decline and tool for measuring same |
| WO2018146184A1 (en) | 2017-02-08 | 2018-08-16 | Koninklijke Philips N.V. | A method and apparatus for monitoring a subject |
| US20180280028A1 (en) | 2011-08-01 | 2018-10-04 | Laminate Medical Technologies Ltd. | Vessel shaping devices and methods |
| US20190307459A1 (en) | 2015-08-13 | 2019-10-10 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| WO2020073094A1 (en) | 2018-10-12 | 2020-04-16 | The Brain Protection Company PTY LTD | A device and diagnostic method for assessing and monitoring cognitive decline |
| WO2020117562A1 (en) | 2018-12-04 | 2020-06-11 | The Brain Protection Company PTY LTD | Combinatorial therapies including implantable damping devices and therapeutic agents for treating a condition and associated systems and methods of use |
| WO2020117560A1 (en) | 2018-12-04 | 2020-06-11 | The Brain Protection Company PTY LTD | Combinatorial therapies including implantable damping devices and therapeutic agents for treating a condition and associated systems and methods of use |
| US20200375721A1 (en) | 2017-11-03 | 2020-12-03 | The Brain Protection Company PTY LTD | Implantable damping device for modifying blood flow characteristics |
| US20210007839A1 (en) | 2010-12-23 | 2021-01-14 | Maquet Cardiovascular Llc | Woven prosthesis and method for manufacturing the same |
| WO2021119737A1 (en) | 2019-12-16 | 2021-06-24 | The Brain Protection Company PTY LTD | A device and method for altering blood flow characteristics in a vessel |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2252894A1 (en) | 1996-04-29 | 1997-11-06 | W. L. Gore & Associates, Inc. | Device for restoring competence to venous valves |
| JP2003024453A (en) | 2001-07-17 | 2003-01-28 | Inprest Co Ltd | Tubular tissue reinforcing member |
| WO2014020565A1 (en) * | 2012-08-01 | 2014-02-06 | Laminate Medical Technologies Ltd. | Apparatus for configuring an arteriovenous fistula |
| US9974671B2 (en) * | 2014-11-03 | 2018-05-22 | Medtronic Vascular, Inc. | Devices and methods for treating aneurysms and other vascular conditions |
| US10181072B2 (en) * | 2016-03-22 | 2019-01-15 | Qualcomm Incorporated | Rollable biometric measuring device |
| JP6836498B2 (en) | 2017-11-30 | 2021-03-03 | 株式会社Screenホールディングス | Blood flow regulator |
-
2020
- 2020-12-16 AU AU2020408369A patent/AU2020408369A1/en active Pending
- 2020-12-16 CN CN202080087823.6A patent/CN115243642A/en active Pending
- 2020-12-16 JP JP2022536722A patent/JP7744343B2/en active Active
- 2020-12-16 EP EP20903223.4A patent/EP4076272A4/en active Pending
- 2020-12-16 WO PCT/AU2020/051377 patent/WO2021119737A1/en not_active Ceased
- 2020-12-16 US US17/785,356 patent/US12490988B2/en active Active
Patent Citations (124)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
| US3726279A (en) | 1970-10-08 | 1973-04-10 | Carolina Medical Electronics I | Hemostatic vascular cuff |
| US4881939A (en) | 1985-02-19 | 1989-11-21 | The Johns Hopkins University | Implantable helical cuff |
| US5002531A (en) | 1986-06-26 | 1991-03-26 | Tassilo Bonzel | Dilation catheter with an inflatable balloon |
| US5100429A (en) | 1989-04-28 | 1992-03-31 | C. R. Bard, Inc. | Endovascular stent and delivery system |
| US5222980A (en) | 1991-09-27 | 1993-06-29 | Medtronic, Inc. | Implantable heart-assist device |
| US5755777A (en) | 1991-10-25 | 1998-05-26 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
| US5618301A (en) | 1993-10-07 | 1997-04-08 | Angiomed Ag | Reducing stent, device with reducing stent and use of a reducing stent |
| US20130066416A1 (en) | 1994-02-09 | 2013-03-14 | Scimed Life Systems, Inc. | Bifurcated endoluminal prosthesis |
| US6350282B1 (en) | 1994-04-22 | 2002-02-26 | Medtronic, Inc. | Stented bioprosthetic heart valve |
| US5634895A (en) | 1994-06-23 | 1997-06-03 | Cormedics Corp. | Apparatus and method for transpericardial delivery of fluid |
| US5702419A (en) | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
| US5800524A (en) | 1994-12-16 | 1998-09-01 | Bard Galway Limited | Prosthesis with spiral stitching element |
| US5800526A (en) | 1995-03-17 | 1998-09-01 | Endotex Interventional Systems, Inc. | Multi-anchor stent |
| WO1996032077A1 (en) | 1995-04-11 | 1996-10-17 | The University Of Queensland | Artificial graft prosthesis |
| US5665117A (en) | 1995-11-27 | 1997-09-09 | Rhodes; Valentine J. | Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use |
| US6042605A (en) | 1995-12-14 | 2000-03-28 | Gore Enterprose Holdings, Inc. | Kink resistant stent-graft |
| US6030336A (en) | 1996-02-21 | 2000-02-29 | Synthelabo Biomedical (Societe Anonyme) | Pressure generator for a counterpressure cardiac assistance device |
| US6010529A (en) | 1996-12-03 | 2000-01-04 | Atrium Medical Corporation | Expandable shielded vessel support |
| US5919224A (en) | 1997-02-12 | 1999-07-06 | Schneider (Usa) Inc | Medical device having a constricted region for occluding fluid flow in a body lumen |
| US6120534A (en) | 1997-10-29 | 2000-09-19 | Ruiz; Carlos E. | Endoluminal prosthesis having adjustable constriction |
| US6241691B1 (en) | 1997-12-05 | 2001-06-05 | Micrus Corporation | Coated superelastic stent |
| US6395019B2 (en) | 1998-02-09 | 2002-05-28 | Trivascular, Inc. | Endovascular graft |
| US6129756A (en) | 1998-03-16 | 2000-10-10 | Teramed, Inc. | Biluminal endovascular graft system |
| WO2001056501A1 (en) | 2000-02-07 | 2001-08-09 | S & G Biotech Inc. | Blood vessel graft and graft introducer |
| US20010027338A1 (en) | 2000-03-03 | 2001-10-04 | Cook Incorporated | Endovascular device having a stent |
| US20110106240A1 (en) | 2000-03-03 | 2011-05-05 | Chuter Timothy A M | Large vessel stents and occluders |
| US20150088239A1 (en) | 2000-03-27 | 2015-03-26 | Neovasc Medical Ltd. | Methods for treating abnormal growths in the body using a flow reducing implant |
| US20070156167A1 (en) | 2000-04-14 | 2007-07-05 | Connors Kevin G | Pressure attenuation device |
| US6974473B2 (en) | 2000-06-30 | 2005-12-13 | Vascular Architects, Inc. | Function-enhanced thrombolytic AV fistula and method |
| US6984201B2 (en) | 2000-09-23 | 2006-01-10 | Harefield Cardiac Limited | Blood circulation assistance device |
| US20060100530A1 (en) | 2000-11-28 | 2006-05-11 | Allez Physionix Limited | Systems and methods for non-invasive detection and monitoring of cardiac and blood parameters |
| US9492293B2 (en) | 2001-03-13 | 2016-11-15 | Medinol Ltd. | Method and apparatus for stenting |
| WO2003028522A2 (en) | 2001-03-27 | 2003-04-10 | Neovasc Medical Ltd. | Flow reducing implant |
| US20020188341A1 (en) | 2001-05-10 | 2002-12-12 | Elliott Christopher J. | Stent with detachable tethers and method of using same |
| US20040010303A1 (en) | 2001-09-26 | 2004-01-15 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
| US20030065303A1 (en) | 2001-09-28 | 2003-04-03 | Wellman Parris S. | Methods and devices for treating diseased blood vessels |
| US20050055082A1 (en) | 2001-10-04 | 2005-03-10 | Shmuel Ben Muvhar | Flow reducing implant |
| US20050049677A1 (en) | 2001-11-09 | 2005-03-03 | Farnan Robert C. | Baloon catherter with non-deployable stent |
| US7125464B2 (en) | 2001-12-20 | 2006-10-24 | Boston Scientific Santa Rosa Corp. | Method for manufacturing an endovascular graft section |
| US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
| US20030125797A1 (en) | 2001-12-20 | 2003-07-03 | Trivascular, Inc. | Advanced endovascular graft |
| US20060106449A1 (en) | 2002-08-08 | 2006-05-18 | Neovasc Medical Ltd. | Flow reducing implant |
| WO2004026112A2 (en) | 2002-09-17 | 2004-04-01 | Tricardia, Llc | Vascular compliance device and method of use |
| US20040106971A1 (en) | 2002-09-17 | 2004-06-03 | Schwartz Robert S. | Sealed membrane vascular compliance device and method |
| US20040143319A1 (en) | 2002-09-17 | 2004-07-22 | Schwartz Robert S. | Vascular pressure differential device and method of use |
| US20040147803A1 (en) | 2002-10-07 | 2004-07-29 | Hegde Anant V. | Vascular assist device and methods |
| US20060052866A1 (en) | 2002-12-19 | 2006-03-09 | Unisearch Limited | Method of treating a stiffened blood vessel |
| WO2004056274A1 (en) | 2002-12-19 | 2004-07-08 | Unisearch Limited | A method of treating a stiffened blood vessel |
| WO2004106971A1 (en) | 2003-05-30 | 2004-12-09 | Mitsubishi Denki Kabushiki Kaisha | Coherent laser radar |
| US20040260384A1 (en) | 2003-06-17 | 2004-12-23 | Medtronic Ave | Superelastic coiled stent |
| US20050021023A1 (en) | 2003-07-23 | 2005-01-27 | Scimed Life Systems, Inc. | System and method for electrically determining position and detachment of an implantable device |
| WO2005041783A1 (en) | 2003-10-30 | 2005-05-12 | Sunshine Heart Company Pty Ltd | A wrap |
| US20080194905A1 (en) | 2004-03-02 | 2008-08-14 | Peter William Walsh | Vessel or Sac Wall Treatment and a Cardiac Assist Device |
| WO2005084730A1 (en) | 2004-03-02 | 2005-09-15 | Peter William Walsh | A vessel or sac wall treatment and a cardiac assist device |
| US7766814B2 (en) | 2004-03-02 | 2010-08-03 | Peter William Walsh | Vessel or sac wall treatment and a cardiac assist device |
| DE102004018255A1 (en) | 2004-04-15 | 2005-11-10 | Universitätsklinikum Schleswig-Holstein | Vessel prosthesis for maintaining the air chamber function of large blood vessel systems, e.g. the aorta, comprises a tube having an inner wall provided with an elastic flexible lining |
| US20060025852A1 (en) | 2004-08-02 | 2006-02-02 | Armstrong Joseph R | Bioabsorbable self-expanding endolumenal devices |
| WO2006062976A2 (en) | 2004-12-07 | 2006-06-15 | Cook Incorporated | Methods for modifying vascular vessel walls |
| US7575594B2 (en) | 2004-12-30 | 2009-08-18 | Sieracki Jeffrey M | Shock dampening biocompatible valve |
| US7819941B2 (en) | 2005-06-08 | 2010-10-26 | Sms Siemag Aktiengesellschaft | Method for reducing and/or refining a metal-containing slag |
| US20090177279A1 (en) | 2005-07-21 | 2009-07-09 | The Cleveland Clinic Foundation | Medical oscillating compliance devices and uses thereof |
| US20110213408A1 (en) | 2005-07-25 | 2011-09-01 | Vascular Dynamics Inc. | Devices and methods for control of blood pressure |
| US20130172981A1 (en) | 2005-07-25 | 2013-07-04 | Vascular Dynamics, Inc. | Devices and methods for control of blood pressure |
| US9125567B2 (en) | 2005-07-25 | 2015-09-08 | Vascular Dynamics, Inc. | Devices and methods for control of blood pressure |
| WO2007038476A2 (en) | 2005-09-26 | 2007-04-05 | Atteneux Technologies, Inc. | Pressure attenuation device |
| US20100030253A1 (en) | 2005-11-18 | 2010-02-04 | C.R. Brard, Inc. | Vena cava filter with filament |
| US20110166240A1 (en) | 2005-12-27 | 2011-07-07 | Monosol Rx, Llc | Ph modulated films for delivery of actives |
| WO2008061185A1 (en) | 2006-11-15 | 2008-05-22 | Georgia Tech Research Corporation | Flow manipulation in biological flows using vortex generators |
| US20110144669A1 (en) | 2007-09-11 | 2011-06-16 | Nfocus Neuromedical Inc. | Aneurysm cover device for embolic delivery and retention |
| US20100056978A1 (en) | 2008-08-27 | 2010-03-04 | Lindsay Machan | Externally adjustable blood flow valve |
| US20110196967A1 (en) | 2008-10-22 | 2011-08-11 | Fujitsu Limited | Communication control apparatus, communication control system, and communication control method |
| US20100256735A1 (en) | 2009-04-03 | 2010-10-07 | Board Of Regents, The University Of Texas System | Intraluminal stent with seam |
| US20130013051A1 (en) | 2009-12-08 | 2013-01-10 | Endospan Ltd. | Endovascular stent-graft system with fenestrated and crossing stent-grafts |
| US20110264116A1 (en) * | 2009-12-31 | 2011-10-27 | Gordon Kocur | Compressive Denervation Apparatus for Innervated Renal Vasculature |
| US8702776B2 (en) | 2010-04-26 | 2014-04-22 | Paul Heltai | Method for deploying a sleeve and tubing device for restricting and constricting aneurysms and a sleeve and tubing device and system |
| US20130218191A1 (en) | 2010-04-26 | 2013-08-22 | Paul Heltai | Method for deploying a sleeve and tubing device for restricting and constricting aneurysms and a sleeve and tubing device and system |
| US20130079871A1 (en) | 2010-06-08 | 2013-03-28 | Regents Of The University Of Minnesota | Vascular elastance |
| WO2012018590A1 (en) | 2010-07-26 | 2012-02-09 | Judah Weinberger | Blood flow controllers and methods |
| US20120089218A1 (en) | 2010-10-11 | 2012-04-12 | Dardi Peter S | Hydrogel jacketed stents |
| WO2012071395A1 (en) | 2010-11-22 | 2012-05-31 | Aria Cv, Inc. | System and method for reducing pulsatile pressure |
| JP5782523B2 (en) | 2010-11-22 | 2015-09-24 | アリア シーブイ, インコーポレイテッド | System and method for reducing pulsating pressure |
| US9017359B2 (en) | 2010-11-22 | 2015-04-28 | Aria Cv, Inc. | System and method for reducing pulsatile pressure |
| US20210007839A1 (en) | 2010-12-23 | 2021-01-14 | Maquet Cardiovascular Llc | Woven prosthesis and method for manufacturing the same |
| US20140058436A1 (en) | 2011-02-18 | 2014-02-27 | Sequent Medical, Inc. | Blood flow disruption devices and methods for the treatment of vascular defects |
| WO2013013081A1 (en) | 2011-07-20 | 2013-01-24 | Stryker Corporaton | Manifold for filling plural cannulae |
| US20180280028A1 (en) | 2011-08-01 | 2018-10-04 | Laminate Medical Technologies Ltd. | Vessel shaping devices and methods |
| US20130226280A1 (en) | 2011-08-29 | 2013-08-29 | Aortic Wrap Pty Ltd | Method and Device For Treating a Stiffened Blood Vessel |
| US8708906B1 (en) | 2011-09-07 | 2014-04-29 | Allen J. Orehek | Method for the prevention of dementia and Alzheimer's disease |
| EP2586402A1 (en) | 2011-10-27 | 2013-05-01 | Cook Medical Technologies LLC | Stent with inwardly-directed protrusion |
| WO2013084235A2 (en) | 2011-12-04 | 2013-06-13 | Endospan Ltd. | Branched stent-graft system |
| US20140350658A1 (en) | 2011-12-04 | 2014-11-27 | Endospan Ltd. | Branched stent-graft system |
| US20130296917A1 (en) | 2012-05-04 | 2013-11-07 | Interventco Llc | Device and Method for Filling of Aneurysm or Body Cavity |
| US9592068B2 (en) | 2013-03-15 | 2017-03-14 | Insera Therapeutics, Inc. | Free end vascular treatment systems |
| WO2014186755A2 (en) | 2013-05-16 | 2014-11-20 | Sarvazyan Narine | Myocyte-derived flow assist device: extravasal sheaths of rhythmically contracting myocytes aiding flow of biological fluids |
| US20150025625A1 (en) | 2013-07-18 | 2015-01-22 | The Trustees Of The University Of Pennsylvania | Cardiac repair prosthesis sets and methods |
| US9039725B1 (en) | 2014-06-19 | 2015-05-26 | Aria Cv, Inc. | Systems and methods for treating pulmonary hypertension |
| US9242082B2 (en) | 2014-06-19 | 2016-01-26 | Aria Cv, Inc. | Systems and methods for treating pulmonary hypertension |
| US8876850B1 (en) | 2014-06-19 | 2014-11-04 | Aria Cv, Inc. | Systems and methods for treating pulmonary hypertension |
| US20170172771A1 (en) | 2014-07-20 | 2017-06-22 | Elchanan Bruckheimer | Pulmonary artery implant apparatus and methods of use thereof |
| WO2016128983A1 (en) | 2015-02-12 | 2016-08-18 | Hemodynamx-Technologies Ltd. | Aortic implant |
| WO2017024357A1 (en) | 2015-08-13 | 2017-02-16 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US20220233200A1 (en) | 2015-08-13 | 2022-07-28 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US20190336133A1 (en) | 2015-08-13 | 2019-11-07 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US20180008279A1 (en) | 2015-08-13 | 2018-01-11 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US20190307459A1 (en) | 2015-08-13 | 2019-10-10 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US20170042551A1 (en) | 2015-08-13 | 2017-02-16 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US20180214157A1 (en) * | 2015-08-13 | 2018-08-02 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US11224433B2 (en) | 2015-08-13 | 2022-01-18 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US10064626B2 (en) | 2015-08-13 | 2018-09-04 | The Brain Protection Company PTY LTD | Implantable damping devices for treating dementia and associated systems and methods of use |
| US20170087045A1 (en) | 2015-09-28 | 2017-03-30 | Michael Zhadkevich | Device and method for simultaneous detection, monitoring and prevention of cerebral emboli |
| US20170354421A1 (en) * | 2016-06-10 | 2017-12-14 | Microvention, Inc. | Vessel Occluder |
| WO2018027298A1 (en) | 2016-08-12 | 2018-02-15 | Gand François | Portable alzheimer detector |
| WO2018064769A1 (en) | 2016-10-04 | 2018-04-12 | Toubib Media Inc. | Method for generating cognitive decline detection tool, method for measuring cognitive decline and tool for measuring same |
| WO2018146184A1 (en) | 2017-02-08 | 2018-08-16 | Koninklijke Philips N.V. | A method and apparatus for monitoring a subject |
| US20170173262A1 (en) | 2017-03-01 | 2017-06-22 | François Paul VELTZ | Medical systems, devices and methods |
| US20200375721A1 (en) | 2017-11-03 | 2020-12-03 | The Brain Protection Company PTY LTD | Implantable damping device for modifying blood flow characteristics |
| WO2020073094A1 (en) | 2018-10-12 | 2020-04-16 | The Brain Protection Company PTY LTD | A device and diagnostic method for assessing and monitoring cognitive decline |
| US20210393189A1 (en) | 2018-10-12 | 2021-12-23 | The Brain Protection Company PTY LTD | A device and diagnostic method for assessing and monitoring cognitive decline |
| WO2020117562A1 (en) | 2018-12-04 | 2020-06-11 | The Brain Protection Company PTY LTD | Combinatorial therapies including implantable damping devices and therapeutic agents for treating a condition and associated systems and methods of use |
| WO2020117560A1 (en) | 2018-12-04 | 2020-06-11 | The Brain Protection Company PTY LTD | Combinatorial therapies including implantable damping devices and therapeutic agents for treating a condition and associated systems and methods of use |
| US20220008229A1 (en) | 2018-12-04 | 2022-01-13 | The Brain Protection Company PTY LTD | Combinatorial therapies including implantable damping devices and therapeutic agents for treating a condition and associated systems and methods of use |
| US20220022881A1 (en) | 2018-12-04 | 2022-01-27 | The Brain Protection Company PTY LTD | Combinatorial therapies including implantable damping devices and therapeutic agents for treating a condition and associated systems and methods of use |
| WO2021119737A1 (en) | 2019-12-16 | 2021-06-24 | The Brain Protection Company PTY LTD | A device and method for altering blood flow characteristics in a vessel |
Non-Patent Citations (50)
| Title |
|---|
| Chen Y-H et al., "Carotid stenting improves cognitive function in asymptomatic cerebral ischemia," International Journal of Cardiology, 2012, Received Jul. 2011, vol. 157, pp. 104-107. |
| Cifuentes et al., "Hypertension Accelerates the Progression of Alzheimer-Like Pathology in a Mouse Model of the Disease," hyper.ahajournals, Jun. 2015, 7 pgs. |
| Cullen, et al. "Microvascular pathology in the aging human brain: Evidence that senile plaques are sites of microhaemorrhages." Neurobiology of Aging (2006) 27, Jan. 2006, pp. 1786-1796. |
| Dickstein D. L. et al., "Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease," Mount Sinai Journal of Medicine, 2010, Published Jan.-Feb. 2010, vol. 77, pp. 82-102. |
| Ding et al., "Carotid Arterial Stiffness and Risk of Incident Cerebral Microbleeds in Older People," Arterioscler Thromb Vasc Biol, Jun. 11, 2015, 7 pgs. |
| English Translation of First Office Action received for co-pending Chinese Patent Application No. 201680048180.8, Date of Mailing: May 13, 2019, Applicant: The Brain Protection Company PTY Ltd, 3 pages. |
| European Search Report received for co-pending European Patent Application No. 16834323.4, Date of Mailing: Apr. 16, 2019, Applicant: The Brain Protection Company PTY Ltd, 10 pages. |
| Examination Report received for co-pending Australian Patent Application No. 2016306711, Date of Mailing: Feb. 7, 2019, Applicant: The Brain Protection Company PTY Ltd, 4 pages. |
| Grunwald I. Q. et al., "Influence of carotid artery stenting on cognitive function," Neuroradiology, 2010, Published online Nov. 2009, vol. 52, pp. 61-66. |
| International Preliminary Report on Patentability issued for International Application No. PCT/AU2016/050734, Applicant: The Brain Protection Company Pty Ltd, Date of Mailing: Jan. 2, 2018, 55 pages. |
| International Preliminary Report on Patentability received for International PCT Application No. PCT/AU2018/051191 filed Nov. 2, 2018; Applicant: The Brain Protection Company Pty Ltd; Date of Mailing: Feb. 10, 2020, 20 pages. |
| International Preliminary Report on Patentability received for International PCT Application No. PCT/AU2020/051377, filed Dec. 16, 2020; Applicant: The Brain Protection Company Pty Ltd; Date of Mailing: Mar. 29, 2022, 20 pages. |
| International Search Report and Written Opinion issued for International Application No. PCT/US19/63294, Applicant: The Brain Protection Company Pty Ltd, Date of Mailing: Apr. 24, 2020, 17 pages. |
| International Search Report and Written Opinion issued for International Application No. PCT/US19/63309, Applicant: The Brain Protection Company Pty Ltd, Date of Mailing: Apr. 21, 2020, 12 pages. |
| International Search Report and Written Opinion received for International PCT Application No. PCT/AU2018/051191 filed Nov. 2, 2018; Applicant: The Brain Protection Company Pty Ltd; Date of Mailing: Jan. 18, 2019, 20 pages. |
| International Search Report and Written Opinion received for International PCT Application No. PCT/AU2019/051101, filed Oct. 11, 2019; Applicant: The Brain Protection Company Pty Ltd; Date of Mailing: Dec. 19, 2019, 16 pages. |
| Lal B. K. et al., "Cognitive changes after surgery vs stenting for carotid artery stenosis," J Vasc Surg, 2011, Mar. 2011, vol. 54, pp. 691-698. |
| Messas et al. "Arterial wall elasticity: State of the art and future prospects," Diagnostic and Interventional Imaging, (2013) 94, http:/ /dx.doi.org/10.1016/j.diii., Jan. 2013, pp. 561-569. |
| Mitchell et al. "Arterial Stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility—Reykjavik Study," Brain (2011) 134; received Aug. 2011, 3398-3407. |
| Power M.C. et al., "The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis," Epidemiology, 2011, Sep. 2011, vol. 22(5), pp. 646-659. |
| Raabe R.D. et al., "One-year Cognitive Outcomes Associated with Carotid Artery Stent Placement," J Vasc Interv Radiol, 2010, vol. 21, DOI: 10.1016/j.jvir., Mar. 2010, pp. 983-988. |
| Richard E. et al., "Prevention of dementia by intensive vascular care (preDIVA); a cluster-randomised trial in progress," Chapter 4.1 Alzheimer disease and associated disorders, Jul. 2009, pp. 46 to 58. |
| Stone et al. "The Mechanical Cause of Age-Related Dementia (Alzheimer's Disease): The Brain is Destroyed by the Pulse," Journal of Alzheimer's Disease (2015) 44; accepted Sep. 2014, pp. 355-373. |
| Sun et al., "Post-stroke cognitive impairment: epidemiology, mechanisms and management," Annals of Translational Medicine, 2014;2(8):80, published on Jul. 18, 2014, 16 pages. |
| Takaiwa A. et al., "Changes in cognitive function during the 1-year period following endarterectomy and stenting of patients with high-grade carotid artery stenosis," Acta Neurochir, 2009, Published online Jun. 2009, vol. 151, pp. 1593-1600. |
| Chen Y-H et al., "Carotid stenting improves cognitive function in asymptomatic cerebral ischemia," International Journal of Cardiology, 2012, Received Jul. 2011, vol. 157, pp. 104-107. |
| Cifuentes et al., "Hypertension Accelerates the Progression of Alzheimer-Like Pathology in a Mouse Model of the Disease," hyper.ahajournals, Jun. 2015, 7 pgs. |
| Cullen, et al. "Microvascular pathology in the aging human brain: Evidence that senile plaques are sites of microhaemorrhages." Neurobiology of Aging (2006) 27, Jan. 2006, pp. 1786-1796. |
| Dickstein D. L. et al., "Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease," Mount Sinai Journal of Medicine, 2010, Published Jan.-Feb. 2010, vol. 77, pp. 82-102. |
| Ding et al., "Carotid Arterial Stiffness and Risk of Incident Cerebral Microbleeds in Older People," Arterioscler Thromb Vasc Biol, Jun. 11, 2015, 7 pgs. |
| English Translation of First Office Action received for co-pending Chinese Patent Application No. 201680048180.8, Date of Mailing: May 13, 2019, Applicant: The Brain Protection Company PTY Ltd, 3 pages. |
| European Search Report received for co-pending European Patent Application No. 16834323.4, Date of Mailing: Apr. 16, 2019, Applicant: The Brain Protection Company PTY Ltd, 10 pages. |
| Examination Report received for co-pending Australian Patent Application No. 2016306711, Date of Mailing: Feb. 7, 2019, Applicant: The Brain Protection Company PTY Ltd, 4 pages. |
| Grunwald I. Q. et al., "Influence of carotid artery stenting on cognitive function," Neuroradiology, 2010, Published online Nov. 2009, vol. 52, pp. 61-66. |
| International Preliminary Report on Patentability issued for International Application No. PCT/AU2016/050734, Applicant: The Brain Protection Company Pty Ltd, Date of Mailing: Jan. 2, 2018, 55 pages. |
| International Preliminary Report on Patentability received for International PCT Application No. PCT/AU2018/051191 filed Nov. 2, 2018; Applicant: The Brain Protection Company Pty Ltd; Date of Mailing: Feb. 10, 2020, 20 pages. |
| International Preliminary Report on Patentability received for International PCT Application No. PCT/AU2020/051377, filed Dec. 16, 2020; Applicant: The Brain Protection Company Pty Ltd; Date of Mailing: Mar. 29, 2022, 20 pages. |
| International Search Report and Written Opinion issued for International Application No. PCT/US19/63294, Applicant: The Brain Protection Company Pty Ltd, Date of Mailing: Apr. 24, 2020, 17 pages. |
| International Search Report and Written Opinion issued for International Application No. PCT/US19/63309, Applicant: The Brain Protection Company Pty Ltd, Date of Mailing: Apr. 21, 2020, 12 pages. |
| International Search Report and Written Opinion received for International PCT Application No. PCT/AU2018/051191 filed Nov. 2, 2018; Applicant: The Brain Protection Company Pty Ltd; Date of Mailing: Jan. 18, 2019, 20 pages. |
| International Search Report and Written Opinion received for International PCT Application No. PCT/AU2019/051101, filed Oct. 11, 2019; Applicant: The Brain Protection Company Pty Ltd; Date of Mailing: Dec. 19, 2019, 16 pages. |
| Lal B. K. et al., "Cognitive changes after surgery vs stenting for carotid artery stenosis," J Vasc Surg, 2011, Mar. 2011, vol. 54, pp. 691-698. |
| Messas et al. "Arterial wall elasticity: State of the art and future prospects," Diagnostic and Interventional Imaging, (2013) 94, http:/ /dx.doi.org/10.1016/j.diii., Jan. 2013, pp. 561-569. |
| Mitchell et al. "Arterial Stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility—Reykjavik Study," Brain (2011) 134; received Aug. 2011, 3398-3407. |
| Power M.C. et al., "The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis," Epidemiology, 2011, Sep. 2011, vol. 22(5), pp. 646-659. |
| Raabe R.D. et al., "One-year Cognitive Outcomes Associated with Carotid Artery Stent Placement," J Vasc Interv Radiol, 2010, vol. 21, DOI: 10.1016/j.jvir., Mar. 2010, pp. 983-988. |
| Richard E. et al., "Prevention of dementia by intensive vascular care (preDIVA); a cluster-randomised trial in progress," Chapter 4.1 Alzheimer disease and associated disorders, Jul. 2009, pp. 46 to 58. |
| Stone et al. "The Mechanical Cause of Age-Related Dementia (Alzheimer's Disease): The Brain is Destroyed by the Pulse," Journal of Alzheimer's Disease (2015) 44; accepted Sep. 2014, pp. 355-373. |
| Sun et al., "Post-stroke cognitive impairment: epidemiology, mechanisms and management," Annals of Translational Medicine, 2014;2(8):80, published on Jul. 18, 2014, 16 pages. |
| Takaiwa A. et al., "Changes in cognitive function during the 1-year period following endarterectomy and stenting of patients with high-grade carotid artery stenosis," Acta Neurochir, 2009, Published online Jun. 2009, vol. 151, pp. 1593-1600. |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7744343B2 (en) | 2025-09-25 |
| EP4076272A4 (en) | 2024-01-10 |
| EP4076272A1 (en) | 2022-10-26 |
| WO2021119737A1 (en) | 2021-06-24 |
| AU2020408369A1 (en) | 2022-06-23 |
| US20240108348A1 (en) | 2024-04-04 |
| JP2023510501A (en) | 2023-03-14 |
| CN115243642A (en) | 2022-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8355777B2 (en) | Apparatus and method for sensor deployment and fixation | |
| EP0565251B1 (en) | Vascular stent | |
| CA2235911C (en) | Stent and stent-graft for treating branched vessels | |
| EP0955950B1 (en) | Flat wire stent | |
| CN219439576U (en) | Tectorial membrane support | |
| US20080319535A1 (en) | Vascular Stent and Method of Making Vascular Stent | |
| WO2019096158A1 (en) | Endovascular stent | |
| CN107920886A (en) | For treating the implanted damping unit and related system and application method of dementia | |
| US12490988B2 (en) | Device and method for altering blood flow characteristics in a vessel | |
| WO2018066568A1 (en) | Flexible stent | |
| AU2021203415A1 (en) | Implantable damping device for modifying blood flow characteristics | |
| CN110623780A (en) | Sectional type tectorial membrane stent and preparation method thereof | |
| US20230385035A9 (en) | Vascular treatment devices and associated systems and methods of use | |
| WO2019128703A1 (en) | Covered stent | |
| CN104918579A (en) | Vascular implant with asymmetric stent springs | |
| AU2015242971A1 (en) | Endoprosthesis with varying compressibility and methods of use | |
| WO2025139956A1 (en) | Covered stent and delivery system | |
| US20070156078A1 (en) | Device for placement externally of a body fluid flow conduit | |
| CN114099062A (en) | Covered stent | |
| WO2023125046A1 (en) | Bare stent and implantable stent | |
| WO2023028279A2 (en) | Compliant endovascular device for thoracic and the thoraco-abdominal aorta | |
| CN116211562A (en) | Bump support | |
| JP2025533283A (en) | stents | |
| CN116327462A (en) | Lumen stent | |
| HK40004070A (en) | Flexible stent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| AS | Assignment |
Owner name: THE BRAIN PROTECTION COMPANY PTY LTD, AUSTRALIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CELERMAJER, DAVID STEPHEN;UJHAZY, ANTHONY;MILIJASEVIC, ZORAN;REEL/FRAME:064169/0243 Effective date: 20191216 Owner name: THE BRAIN PROTECTION COMPANY PTY LTD, AUSTRALIA Free format text: ASSIGNMENT OF ASSIGNOR'S INTEREST;ASSIGNORS:CELERMAJER, DAVID STEPHEN;UJHAZY, ANTHONY;MILIJASEVIC, ZORAN;REEL/FRAME:064169/0243 Effective date: 20191216 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: ALLOWED -- NOTICE OF ALLOWANCE NOT YET MAILED Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |